Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Angiogenesis Research

Background:

• Mesenchymal stem cells (MSCs) are promising for regenerative therapies due to their differentiation potential.
• MSCs exhibit trophic activities, including promoting vasculature formation (vasculogenesis).
• While bone marrow is a known source, MSCs are found in other adult tissues, raising questions about their functional uniformity.

Purpose of the Study:

• To investigate if the vasculogenic potential of MSCs is consistent across different tissue origins.
• To compare the ability of MSCs from bone marrow, adipose tissue, skeletal muscle, and myocardium to modulate endothelial cell function and vascular network formation.

Main Methods:

• MSCs were isolated from four distinct murine tissues: bone marrow, white adipose tissue, skeletal muscle, and myocardium.
• In vitro assays assessed MSCs' effects on endothelial colony-forming cells (ECFCs) proliferation, migration, and tube formation.
• In vivo studies involved co-implantation of MSCs and ECFCs to evaluate vascular network development.

Main Results:

• All four MSC populations secreted pro-angiogenic factors, significantly enhancing ECFC proliferation, migration, and tube formation in vitro.
• Co-implantation of MSCs and ECFCs in vivo resulted in extensive vascular networks, with ECFCs forming lumens and MSCs supporting perivascularly.
• No significant differences were observed in the vasculogenic capacity among MSCs from the four evaluated tissues.

Conclusions:

• The capacity of mesenchymal stem cells to modulate blood vessel formation is a ubiquitous property, independent of their tissue of origin.
• These findings support the use of MSCs from multiple adult tissues as a consistent source for cell-based vascular therapies.
• This broadens the potential applications of MSCs in regenerative medicine and tissue engineering.